AtriCure Inc
NASDAQ:ATRC

Watchlist Manager
AtriCure Inc Logo
AtriCure Inc
NASDAQ:ATRC
Watchlist
Price: 33.66 USD 0.45% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
AtriCure Inc?
Write Note

Intrinsic Value

ATRC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ATRC stock under the Base Case scenario is 51.52 USD. Compared to the current market price of 33.66 USD, AtriCure Inc is Undervalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATRC Intrinsic Value
51.52 USD
Undervaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
AtriCure Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ATRC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ATRC?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about AtriCure Inc

Provide an overview of the primary business activities
of AtriCure Inc.

What unique competitive advantages
does AtriCure Inc hold over its rivals?

What risks and challenges
does AtriCure Inc face in the near future?

Has there been any significant insider trading activity
in AtriCure Inc recently?

Summarize the latest earnings call
of AtriCure Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AtriCure Inc.

Provide P/S
for AtriCure Inc.

Provide P/E
for AtriCure Inc.

Provide P/OCF
for AtriCure Inc.

Provide P/FCFE
for AtriCure Inc.

Provide P/B
for AtriCure Inc.

Provide EV/S
for AtriCure Inc.

Provide EV/GP
for AtriCure Inc.

Provide EV/EBITDA
for AtriCure Inc.

Provide EV/EBIT
for AtriCure Inc.

Provide EV/OCF
for AtriCure Inc.

Provide EV/FCFF
for AtriCure Inc.

Provide EV/IC
for AtriCure Inc.

Show me price targets
for AtriCure Inc made by professional analysts.

What are the Revenue projections
for AtriCure Inc?

How accurate were the past Revenue estimates
for AtriCure Inc?

What are the Net Income projections
for AtriCure Inc?

How accurate were the past Net Income estimates
for AtriCure Inc?

What are the EPS projections
for AtriCure Inc?

How accurate were the past EPS estimates
for AtriCure Inc?

What are the EBIT projections
for AtriCure Inc?

How accurate were the past EBIT estimates
for AtriCure Inc?

Compare the revenue forecasts
for AtriCure Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AtriCure Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AtriCure Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of AtriCure Inc compared to its peers.

Compare the P/E ratios
of AtriCure Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing AtriCure Inc with its peers.

Analyze the financial leverage
of AtriCure Inc compared to its main competitors.

Show all profitability ratios
for AtriCure Inc.

Provide ROE
for AtriCure Inc.

Provide ROA
for AtriCure Inc.

Provide ROIC
for AtriCure Inc.

Provide ROCE
for AtriCure Inc.

Provide Gross Margin
for AtriCure Inc.

Provide Operating Margin
for AtriCure Inc.

Provide Net Margin
for AtriCure Inc.

Provide FCF Margin
for AtriCure Inc.

Show all solvency ratios
for AtriCure Inc.

Provide D/E Ratio
for AtriCure Inc.

Provide D/A Ratio
for AtriCure Inc.

Provide Interest Coverage Ratio
for AtriCure Inc.

Provide Altman Z-Score Ratio
for AtriCure Inc.

Provide Quick Ratio
for AtriCure Inc.

Provide Current Ratio
for AtriCure Inc.

Provide Cash Ratio
for AtriCure Inc.

What is the historical Revenue growth
over the last 5 years for AtriCure Inc?

What is the historical Net Income growth
over the last 5 years for AtriCure Inc?

What is the current Free Cash Flow
of AtriCure Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for AtriCure Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AtriCure Inc

Current Assets 269.3m
Cash & Short-Term Investments 130.3m
Receivables 54.9m
Other Current Assets 84m
Non-Current Assets 345.8m
PP&E 49.6m
Intangibles 293.1m
Other Non-Current Assets 3m
Current Liabilities 74.4m
Accounts Payable 103.5m
Accrued Liabilities 41.5m
Other Current Liabilities -70.6m
Non-Current Liabilities 75.6m
Long-Term Debt 61.9m
Other Non-Current Liabilities 13.8m
Efficiency

Earnings Waterfall
AtriCure Inc

Revenue
447.6m USD
Cost of Revenue
-112.9m USD
Gross Profit
334.7m USD
Operating Expenses
-368.9m USD
Operating Income
-34.2m USD
Other Expenses
-4.8m USD
Net Income
-38.9m USD

Free Cash Flow Analysis
AtriCure Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ATRC Profitability Score
Profitability Due Diligence

AtriCure Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
38/100
Profitability
Score

AtriCure Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

ATRC Solvency Score
Solvency Due Diligence

AtriCure Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
Low D/E
70/100
Solvency
Score

AtriCure Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATRC Price Targets Summary
AtriCure Inc

Wall Street analysts forecast ATRC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRC is 41.95 USD with a low forecast of 26.26 USD and a high forecast of 63 USD.

Lowest
Price Target
26.26 USD
22% Downside
Average
Price Target
41.95 USD
25% Upside
Highest
Price Target
63 USD
87% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ATRC?

Click here to dive deeper.

Dividends

AtriCure Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ATRC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ATRC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

AtriCure Inc Logo
AtriCure Inc

Country

United States of America

Industry

Health Care

Market Cap

1.6B USD

Dividend Yield

0%

Description

AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 875 full-time employees. The company went IPO on 2005-08-05. The company develops, manufactures, and sells devices for the surgical ablation of cardiac tissue, systems designed for the exclusion of the left atrial appendage and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers. Its ablation and left atrial appendage management (LAAM) products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its products for appendage management include AtriClip System and LARIAT System.

Contact

OHIO
Mason
7555 Innovation Way
+15137554100.0
www.atricure.com

IPO

2005-08-05

Employees

875

Officers

CEO, President & Director
Mr. Michael H. Carrel
Chief Financial Officer
Ms. Angela L. Wirick CPA
Chief Operating Officer
Mr. Douglas J. Seith
Chief Technical Officer
Mr. Salvatore Privitera J.D.
Chief Legal Officer
Mr. Karl S. Dahlquist CCEP, J.D.
Chief Scientific Officer
Dr. Vinayak Doraiswamy Ph.D.
Show More
Vice President of Corporate Marketing & Communications
Valerie Storch-Willhaus
Chief Marketing & Strategy Officer
Mr. Justin J. Noznesky
Chief Human Resources Officer
Ms. Deborah Yount
Show Less

See Also

Discover More
What is the Intrinsic Value of one ATRC stock?

The intrinsic value of one ATRC stock under the Base Case scenario is 51.52 USD.

Is ATRC stock undervalued or overvalued?

Compared to the current market price of 33.66 USD, AtriCure Inc is Undervalued by 35%.

Back to Top